AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 FEB 15 - (NewsRx.com) -- Women with recurrent early pregnancy loss - or miscarriage - no longer need to be routinely screened for bacteria or viruses or tested for glucose tolerance and thyroid abnormalities, according to the latest document released by The American College of Obstetricians and Gynecologists (ACOG).
The routine use of these tests is not beneficial and thus not recommended in the evaluation of otherwise healthy women with recurrent miscarriages, ACOG said on January 31, 2001.
For recurrent pregnancy loss, ACOG does recommend testing couples for genetic abnormalities and testing women for certain antibodies and anticoagulants that can cause a woman's body to reject the fetus.
Recurrent early pregnancy loss is defined as at least two or three, or more, consecutive pregnancy losses in the first or early second trimester (less than 15 weeks gestation). It is one of the most common clinical problems in reproduction, yet a definite cause can be established in only 50% of the cases, sometimes leaving patients distraught and frustrated.
Matters are further complicated, according to the document, by the inundation of widely varying studies and guidelines in the field of recurrent early pregnancy loss. As a result, patients and physicians may turn to alternative therapies or unproven hypotheses. With "Management of Early Pregnancy Loss," ACOG identifies potential causes and useful treatments in the management of recurrent miscarriage. The practice bulletin reviews the most recent guidelines, studies, and other ...
Source: HighBeam Research, ACOG Releases Recommendations for Management of Recurrent...